Interestingly, poorer tumor-related characteristics such as larger tumor size, vascular invasion, positive AFP level, poorer tumor grade, and distant extension were associated with a decreased risk of developing SPMs, furthermore, patients who received treatments such as local tumor destruction, hepatectomy, and transplantation were related to a higher risk of developing SPMs. This evidence concerns the gene AFP and secondary progressive multiple sclerosis.